Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?


Drug Profile


Alternative Names: TFC 039; Wangeliejin; Wanpagliflozin

Latest Information Update: 08 Jul 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Sirona Biochem
  • Developer Sirona Biochem; Wanbang Biopharma
  • Class Antihyperglycaemics; Carbohydrates; Obesity therapies
  • Mechanism of Action Sodium-glucose transporter 2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes
  • Available For Licensing Yes - Diabetes mellitus

Highest Development Phases

  • Phase I Type 2 diabetes mellitus
  • No development reported Obesity

Most Recent Events

  • 05 Jul 2019 Wanbang Biopharma plans towards full CFDA approval of TFC 039 for Type 2 diabetes mellitus in China
  • 03 Jul 2019 Phase-I clinical trials in Type 2 diabetes mellitus in China (PO)
  • 30 Jan 2019 TFC 039 is still in preclinical trials for Type 2 diabetes mellitus in China
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top